Aspirin and non steroidal anti-inflammatory drugs hypersensitivity: Review (2002-2004)

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 7, 2005, Pages 279-282

  Touraine, F ^a   Moldovan, D ^a   Touraine, P ^b   Chenot, P ^c   Bonnaud, F ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b Dermatologie   (France)

^c NONE

Author keywords

Aspirin hypersensitivity; Aspirin induced asthma; In vitro diagnostic; Leucotriene antagonist desensitization; Lipoxins staphylococcus

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN E2; STAPHYLOCOCCUS ENTEROTOXIN;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; DESENSITIZATION; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG USE; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PROVOCATION TEST; REVIEW; RHINITIS; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG HYPERSENSITIVITY; HUMANS;

EID: 26044472429     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Saint Laudy J. - Acide acetyl salicylique: hypersensibilité, intolérance ou allergie? Allergie. Immunologie. 2001;3:120-6.
2. Jenkins Ch., Costello J., Hodle L. - Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434-7.
3. Kasper L., Sladek K., Duplaga M., Bochenek C., Liebhart J., Gladysz V., Malolepszy J., Szczeklic A. - Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy 2003;58:1064-1066.
4. Vally H., Taylor M.-L., Thompson P.-J. - The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002;569-574.
5. Stevenson D. - Aspirin and NSAID sensitivity. Immunol. Allergy. Clin. N. Am. 2004;24:491-505.
6. Szczeklic A., Stevenson D. - Aspirin induced asthma: advances in pathogenesis, diagnosis and management. J. Allergy. Clin. Immunol 2003;111:913-21.
7. Celik G., Misirligil Z. - Lipoxins in asthma. J. Allergy. Clin. Immunol 2004;114:992.
8. Levy B., Serhan Ch. - Exploring new approches to the treatment of asthma: potential roles for lipoxins and aspirin triggered lipid mediators. Drugs of today 2003;39(5):373-384.
9. Bonnans C., Vachieri Chavis C., Godard P., Bousquet J., Chanez P. - Lipoxins are potential endogenous anti inflammatory mediators in asthma. Am. J. Respir. Crit. Care. Med. 2002;165:1531-1535.
10. Kowalski M., Ptasinska A., Bienkiewicz B., Panliczak R., Dubuskel. - Differential effects of aspirin and misoprostol on 15 hydroxyeicosatetraenoic acid generation by leucocytes from aspirin sensitive asthmatic patients. J. Allergy. Clin. Immunol 2003;112:505-12.
11. Sanak M., Levy B., Clish C., Chiang N., Gronert K., Mastalerz L., Serhan C., Szczeklik A. - Aspirin tolerant asthmatics generate more lipoxins than aspirin intolerant asthmatics. Eur. Respir. J. 2000;16:44-49.
12. Suh Y., Yoon S., Sampson A., Kim H., Kim S., Nahm D., Suh C., Park H. - Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin intolerant asthma. Clin. Exp. Allergy. 2004;34:1270-1275.
13. Bachert C., Gevaerts P., Howard P., Holtapels G., Launenberge Johansson S. - IgEs to staphylococcus aureus enterotoxins in serum is related to severity of astha. J. Allergy. Clin. Immuno 2003;111:1131-1132.
14. Vanzele T., Gevaert P., Watelet J., Claeys G., Holtapels G., Clayes C., Lauwenberge P., Bachert C. - Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J. Allergy. Immunol 2004;114:981-83.
15. Mastalerz L., Setkowicz M., Sanak M., Szczeklik A. - Hypersensitivity to aspirin: common eicosanoid alteration in urticaria and asthma. J. Allergy. Clin. Immunol. 2004;113:771-5.
16. Cousin F., Philips K., Vincent L., Favier B., Bienvenu S., Nicolas J.-F. - Urticaires médicamenteuses Aspirine et AINS: intolérance et allergie. John Libbey-Eurotext 2001;69-81.
17. Demoly P. - Aspirine et AINS: intolérance et allergie. John Libbey-Eurotext 2001;105-108.
18. Van Puijenbroek, Egberts A., Meyboom R., Leufkens H. - Different risks for NSAID induced anaphylaxis. The annals of pharmacotherapy 2002;36(1):24-29.
19. Sanchez-Borges M., Capriles-Hulett A. - Atopy is a risk factor non steroidal anti inflammatory drug sensitivity. Ann. Allergy. Asthma. Immunol 2000;84:101-106.
20. Gamboa P., Sanz M., Caballero M., Urrutia I., Antepara I., Esparza R., De Week A. - The Flow cytometric determination of basophil activation induced by aspirin and other non steroïdal anti inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin. Exp. Allergy 2004;34:1448-1457.
21. Dahlen S., Malmastrom K., Nizankowsica E., Dalhen B., Kuna P., Kowalski M., Lumry N., Picado C., Stevenson D., Bousquet J., Pauwels R., Holgate S., Shahane A., Zhang J., Reiss T., Szczeklik A. - Improvement of aspirin intolerant asthma by montelukast a leucotriene antagonist. Am. J. Respir. Crit. Care. Med 2002;165:9-14.
22. Eymard B., Cousin F., Nicolas J.-F. - Prévention d'un angio-œdème à l'aspirine par l'association antileucotriene/antihistaminique. Am. Dermatol. Venerol. 2003;130:787-8.
23. Erbagci Z. - The leucotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind placebo controlled, crossover clinical study. J. Allergy. Clin. Immunol 2002;110:484-8.
24. Berges-Gimeno M., Simon R., Stevenson D. - Long term treatment with aspirin desensitization in asthmatic patients with aspirin exacerbated respiratory disease. J. Allergy. Clin. Immunol. 2003;111:180-6.
25. Gyllfords P., Bochenek G., Overholt J., Drupka D., Kumlin M., Sheller J., Nizankowska E., Isakson P., Mejza F., Lefkowith J., Dalhen S., Szczeklik A., Murray J., Dalhen B. - Biochimical and clinical evidence that aspirin intolerant asthmatic subjects tolerate the cycloxygenase 2 selective analgesic drug celecoxib. J. Allergy. Clin. Immunol. 2003;111:1116-21.
26. Mommens V., Just N., Ngo M., Cotte L., Fournier C., Wallaert B. - Intolérance aux anti-inflammaroires non stéroïdiens inhibiteurs spécifiques de la cyclo-oxygénase 2. Revue Française d'allergie et d'immunologie clinique 2003;43:393-396.
27. Sanchez-Borges M., Capriles-Hulett A., Caallero-Fonseca F. - Cutaneous reactions to aspirin and non steroidal anti inflammatory drugs. Clinical review in allergy and immunology 2003;24:125-135.